January 25, 2023 02:55 PM EST
Pharma
FDA+

FDA sends warn­ing let­ter to com­mu­ni­ty hos­pi­tal re­view board over re­search con­cerns

Tyler Patchen

News Reporter

An in­sti­tu­tion­al re­view board (IRB) for a hos­pi­tal in South Flori­da has been hit with a warn­ing let­ter from the FDA over con­cerns raised dur­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times